a public good project by the
Synthesis
Company
of California

© 2026

Kara L. Davis | doi.page

0 works0 citations0 h-index

Kara L. Davis

Center for Cancer and Blood Disorders(US)Stanford Cancer InstituteStanford University(US)

Publications by Year

Research Areas

CAR-T cell therapy research, Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Immune Cell Function and Interaction, Single-cell and spatial transcriptomics

Most-Cited Works

→ Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia(2018)5,468 cited
→ Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis(2015)2,513 cited
→ viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia(2013)1,629 cited
→ Single-Cell Trajectory Detection Uncovers Progression and Regulatory Coordination in Human B Cell Development(2014)981 cited
→ GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas(2022)751 cited
→ CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial(2021)545 cited

→ Automated mapping of phenotype space with single-cell data(2016)

451 cited

→ Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial(2022)326 cited

→ Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1–2 trial(2020)312 cited

→ Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse(2018)150 cited